Introduction: Mapping the most common neoplasms in children in the Lower Tocantins region, in Pará, highlights epidemiological data that require attention in order to outline strategies that seek to mitigate the damage caused, ensure timely recovery and, simultaneously, reduce pressure on the health system. Objective: The present study aims to analyze the prevalence of the main types of cancer in children in the Baixo-Tocantins region in the years 2014-2024. Methodology: The data for this research were extracted from the Hospital Information System (SIH/SUS) database, which showed a predominance of the neoplasms in question in relation to the child population in the municipalities of Baixo-Tocantins (Abaetetuba, Acará, Baião, Barcarena, Cametá, Igarapé-Miri, Mocajuba, Moju, Oeiras do Pará and Tailândia). Results: It was found that during the study period, there were 906 cases of leukemia; 289 of benign neoplasms in situ and of uncertain behavior; 117 of malignant neoplasms of bone and articular cartilage; 113 cases of malignant neoplasia of the eyes and adnexa and 95 cases of malignant neoplasia of the mesothelial tissue and soft tissues in children during the selected period, with children aged 1 to 4 years being the most affected by the disease. This is an alarming indicator, especially because it manifests itself in the first decades of life of affected children, negatively impacting their development in all aspects inherent to a full life. Given the above, it is essential to adopt interventions based on scientific evidence in order to guide and improve clinical management. Conclusion: The neoplasms discussed in this study have an optimistic prognosis, directly related to their staging, which makes this a preponderant factor for effective and personalized treatment for the individual. For this, early diagnosis is essential. In light of this, the prevalence of cases, especially leukemia, at such early ages, highlights the urgency of interventions to mitigate the impacts of this condition on children, in addition to relieving the pressure on the health system of northeastern Pará. Therefore, these elements constitute imperative premises for planning predictive public policies.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
